Purpose: Pharmacotherapeutic options for the treatment of preeclampsia are reviewed. Summary: Risk factors for the development of preeclampsia include microvascular diseases, such as diabetes ...

The presence of severe preeclampsia (systolic blood pressure of ≥160 mm Hg or diastolic blood pressure of ≥110 mm Hg) requires hospital admission, treatment with i.v. antihypertensive agents ...

Lindsay Orr was active and healthy, running marathons and hiking all around Colorado. During pregnancy, she developed a ...

Many women lack access to lifesaving treatments and effective care during and after pregnancy and birth. This has led to many maternal deaths due to related conditions.In a new study, the World Health ...

These findings may have profound implications for the diagnosis, treatment and prevention of ... retardation and the clinical syndrome termed preeclampsia (Greek for “before the lightning ...

Preeclampsia greatly increases severe maternal morbidity risk. Targeted prenatal monitoring is key, especially for patients ...

Preeclampsia poses significant risks to maternal and fetal health, including high maternal morbidity, intrauterine growth restriction, placental abruption, preterm birth, and stillbirth. Long-term, it ...

This makes proactive treatment challenging ... but we believe it is integral to developing preeclampsia," said Dr. Swati Shree, a UW Medicine OB-GYN and co-corresponding author of the paper.

Read before the Obstetrical Society of Boston, Nov. 19, 1901.

Read before the Obstetrical Society of Boston, Nov. 19, 1901.

This condition is called triploidy. A fetus with this extra chromosome is said to be unable to survive. Here are the causes ...

When Emily Rosenfeld was doing a fellowship in maternal-fetal medicine at Rutgers Robert Wood Johnson Medical School (RWJMS), ...